Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Improved clinical competence - tearing down the barriers to market for a unique in vitro diagnostic

Reference number
Coordinator Celluminova AB
Funding from Vinnova SEK 100 000
Project duration January 2024 - March 2024
Status Completed
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Skills enhancement in small businesses 2023

Purpose and goal

The MedTech4Health project has allowed Celluminova to acquire competences and tools needed for successful customer interactions for our in vitro diagnostic product, GlioStem-B. We will continue to build on this competence as the company grows with the aim that our product shall provide a much needed tool for neurosurgeons and, with time, benefit patients with malignant glioma.

Expected results and effects

** Denna text är maskinöversatt ** The MedTech4Health project has led to increased clinical competence of Celluminova´s staff and thus increased opportunities to initiate clinical collaborations and set up well-designed clinical studies that benefit both Celluminova, surgeons and, most importantly, the patients.

Planned approach and implementation

** Denna text är maskinöversatt ** The project has been carried out together with a consultant and has taken place through training, discussions and own work. Celluminova is very satisfied with both the project and the collaboration.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 17 May 2024

Reference number 2023-04013

Page statistics